XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
  Anti-Inflammatory
  Antivirals
  Antihypertensives
  Anticholesterol
  Anti-Clotting Drugs
  Anti Cancer Drugs
  Hypnotics
  PPI
  Antibiotics
  Analgesics
  Surfactants
  Fatty Acids
  Adrenergics
  Metals
  Varenicline
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Pharmacology Channel
subscribe to Pharmacology newsletter

Latest Research : Pharmacology

   DISCUSS   |   EMAIL   |   PRINT
BOTOX(R) (Botulinum Toxin Type A) completes 15 Years
Dec 27, 2004, 23:15, Reviewed by: Dr.



 
Doctor Michael Kane, a leading New York plastic surgeon, explains:

DOCTOR MICHAEL KANE SAYS:

"Over the last 15 years, BOTOX(R) has been used to treat millions of patients worldwide who suffer from a variety of medical conditions. The same product was approved as BOTOX(R) Cosmetic in 2002 for the temporary treatment of frown lines between the brows. Today, BOTOX(R) Cosmetic is one of the most popular, physician-administered aesthetic prescription procedures."

VOICE OVER: For more information about BOTOX(R) or BOTOX(R) Cosmetic visit http://www.botox.com and http://www.botoxcosmetic.com .

AUDIO PROVIDED BY: Allergan, Inc.

Important Safety Information About BOTOX(R) and BOTOX(R) Cosmetic BOTOX(R) and BOTOX(R) Cosmetic should only be administered by a trained and qualified physician. BOTOX(R) and BOTOX(R) Cosmetic treatments are contraindicated in the presence of infection at the proposed injection sites and in individuals with known hypersensitivity to any ingredient in the formulation. Serious and/or immediate hypersensitivity reactions have been rarely reported. Individuals with peripheral motor neuropathic diseases (e.g., amyotrophic lateral sclerosis, or motor neuropathy) or neuromuscular junctional disorders (e.g., myasthenia gravis or Lambert-Eaton syndrome) should only receive BOTOX(R) or BOTOX(R) Cosmetic with caution. Patients with neuromuscular disorders may be at increased risk of clinically significant systemic effects including severe dysphagia and respiratory compromise from typical doses of BOTOX(R) or BOTOX(R) Cosmetic. The most common side effects with Botox Cosmetic include headache, respiratory infection, flu syndrome, temporary eyelid droop and nausea.
http://www.botox.com http://www.botoxcosmetic.com
 

-
 

BOTOX Website

 
Subscribe to Pharmacology Newsletter
E-mail Address:

 



Related Pharmacology News

Phase Ib Trial Is Evaluating Bavituximab Administered With Common Chemotherapy Regimens
Two-component lantibiotic with therapeutic potential discovered
Prescription pain medication abuse on rise
Antibiotic inhibits cancer gene activity
NRTIs limits the atherogenic side effect of the protease inhibitors
Cyclin-dependent kinase inhibitors: The latest anti-inflammatory
FDA requested to promptly approve 17-P to prevent premature birth
Rapamycin shown to inhibit angiogenesis
Tigecycline, world�s first glycylcycline expanded broad-spectrum antibiotic, launched in UK
Ibuprofen - worsening cognitive function


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us